Filtered By:
Source: Heart, Lung and Circulation
Education: Study

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 79 results found since Jan 2013.

Amplatzer PFO Occluder Device may Prevent Recurrent Stroke in Patients with Patent Foramen Ovale and Cryptogenic Stroke: A Meta-Analysis of Randomised Trials
Conclusion: The closure of PFO with Amplatzer PFO occluder device was associated with significant reduction in recurrent strokes in patients with cryptogenic stroke and patent foramen ovale. The better outcome in prevention of secondary stroke in patients with cryptogenic stroke and PFO may be associated with type of closure device used.
Source: Heart, Lung and Circulation - February 4, 2014 Category: Cardiology Authors: Anil Pandit, Madan Raj Aryal, Aashrayata Aryal Pandit, Leena Jalota, Sudheer Kantharajpur, Fayaz A. Hakim, Howard R. Lee Tags: Reviews Source Type: research

Is Atrial Fibrillation a Stroke Risk Factor or Risk Marker? An Appraisal Using the Bradford Hill Framework for Causality
Atrial fibrillation (AF) is strongly associated with stroke risk but association on its own does not necessarily imply causality. Is AF a cause (risk factor) of stroke? Would treatment that reduces AF burden also reduce the burden of stroke? Or, perhaps, AF is a risk marker associated with a vascular syndrome in which there is co-existing atrial structural and electrical remodelling that results in the clinical manifestation of AF and the risk of stroke in parallel. A number of recent studies appear to detach AF as a direct cause of stroke.
Source: Heart, Lung and Circulation - August 13, 2019 Category: Cardiology Authors: V. Malik, A.N. Ganesan, J.B. Selvanayagam, D.P. Chew, A.D. McGavigan Tags: Review Source Type: research

Is Transcatheter Closure Better than Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale? A Meta-analysis of Randomised Trials
Conclusions: In patients with cryptogenic stroke or TIA who had a patent foramen ovale, closure with a device does not confer an advantage over medical therapy and is associated with adverse events like major vascular complication and atrial fibrillation.
Source: Heart, Lung and Circulation - September 13, 2013 Category: Cardiology Authors: Vinayak Nagaraja, Jwalant Raval, Guy D. Eslick, David Burgess, A. Robert Denniss Tags: Reviews Source Type: research

Who Gets Stroke Prevention? Stroke Prevention in Atrial Fibrillation Patients in the Inpatient Setting.
Current guidelines strongly recommend antithrombotic therapy, particularly warfarin, for stroke prevention in atrial fibrillation (AF) patients at high risk of stroke. Despite this, use of these medications is far from optimal. The aim of this study was to describe the use of stroke prevention medication in inpatients and identify factors associated with prescription in one local health district in Sydney, Australia.
Source: Heart, Lung and Circulation - December 23, 2014 Category: Cardiology Authors: Robyn Gallagher, Kellie Roach, Leonie Sadler, Julie Belshaw, Ann Kirkness, Ling Zhang, Ross Proctor, Lis Neubeck Source Type: research

Stroke Recurrence in Embolic Stroke of Undetermined Source Without Atrial Fibrillation on Invasive Cardiac Monitoring
This study investigated the predictors and prognosis of recurrent stroke in ESUS without AF on ICM.
Source: Heart, Lung and Circulation - June 6, 2023 Category: Cardiology Authors: Eugene S.J. Tan, Jhobeleen de Leon, Elaine Boey, Howe-Keat Chin, Kian-Hui Ho, Shana Aguirre, Ming-Gin Sim, Swee-Chong Seow, Vijay K. Sharma, Pipin Kojodjojo Tags: Original Article Source Type: research

Influencing Factors for Early Acute Cerebrovascular Accidents in Patients with Stroke History following Off-pump Coronary Artery Bypass Grafting
Conclusions: This study indicated that patients with severe bilateral carotid stenosis, the left ventricular ejection fraction ≤35%, the postoperative acute myocardial infarction, postoperative atrial fibrillation and postoperative hypotension were more likely to suffer from early acute cerebrovascular accidents when they received OPCAB. Application of Enclose® II proximal anastomotic device may decrease the incidence of early acute cerebrovascular accidents during OPCAB.
Source: Heart, Lung and Circulation - February 10, 2014 Category: Cardiology Authors: Bin Wang, Ming Jia, Shijie Jia, Jiuhe Wan, Xiao Zhou, Zhimin Luo, Ye Zhou, Jianqun Zhang Tags: Original Articles Source Type: research

Relationship between Atherosclerotic Risk Factors and Aortic Plaques in Patients with First-ever Ischaemic Stroke
Aortic plaque is considered a risk factor of ischaemic stroke, and both ulceration and plaque thickness are considered important. However, the relative importance of aortic plaque and carotid plaque remains unclear. The purpose of this study is to clarify the relation between aortic and carotid plaque lesions and atherosclerotic risk factors in patients with acute ischaemic stroke.
Source: Heart, Lung and Circulation - June 5, 2014 Category: Cardiology Authors: Atsushi Mizuma, Chikage Kijima, Kazuyuki Iijima, Yoshiaki Goto, Kazunari Honma, Takashi Yasuda, Kentaro Tokuoka, Yasuhisa Kitagawa, Shunya Takizawa Source Type: research

Endovascular Therapy Proven for Stroke – Finally!
Cardiologists often remark that the field of ischaemic stroke follows in the footsteps of cardiology, just one to two decades later. In the case of endovascular reperfusion therapies this certainly seems to have been the case but there are now multiple positive randomised trials establishing the benefit of mechanical thrombectomy over and above standard care, which included intravenous alteplase in most cases. We will outline the new evidence, contrast the recent trials with the earlier negative studies and discuss some important differences between acute myocardial infarction and ischaemic stroke and the techniques required to treat them.
Source: Heart, Lung and Circulation - April 21, 2015 Category: Cardiology Authors: Bruce C.V. Campbell, Peter J. Mitchell, Richard J. Dowling, Bernard Yan, Geoffrey A. Donnan, Stephen M. Davis Tags: Editorial Source Type: research

Efficacy and Safety of Percutaneous Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation: A meta-analysis of contemporary studies
Percutaneous left atrial appendage (LAA) occlusion has emerged as an important treatment for patients with nonvalvular atrial fibrillation (NVAF) who are at high stroke risk and have contraindications for anticoagulation. However, literature about the efficacy and safety of LAA occlusion is minimal to date. We performed a meta-analysis to assess the rates of stroke events and adverse events for patients treated with occlusion devices.
Source: Heart, Lung and Circulation - May 1, 2016 Category: Cardiology Authors: Haiyan Xu, Xiongwei Xie, Bingjian Wang, Shuren Ma, Fang Wang Source Type: research

Stroke in Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention: Insights From the CADOSA Registry
The objective of this study was to assess the prevalence of periprocedural stroke in contemporary Australian practice.
Source: Heart, Lung and Circulation - July 26, 2016 Category: Cardiology Authors: L. Halliday, R. Tavella, M. Arstall, D. Chew, M. Worthley, C. Zeitz, J. Beltrame Tags: 464 Source Type: research

Efficacy and Safety of Percutaneous Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Meta-analysis of Contemporary Studies
Percutaneous left atrial appendage (LAA) occlusion has emerged as an important treatment for patients with nonvalvular atrial fibrillation (NVAF) who are at high stroke risk and have contraindications for anticoagulation. However, literature about the efficacy and safety of LAA occlusion is minimal to date. We performed a meta-analysis to assess the rates of stroke events and adverse events for patients treated with occlusion devices.
Source: Heart, Lung and Circulation - May 1, 2016 Category: Cardiology Authors: Haiyan Xu, Xiongwei Xie, Bingjian Wang, Shuren Ma, Fang Wang Tags: Original Article Source Type: research

Stroke in Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention: Insights From the CADOSA Registry
The objective of this study was to assess the prevalence of periprocedural stroke in contemporary Australian practice.
Source: Heart, Lung and Circulation - July 27, 2016 Category: Cardiology Authors: L. Halliday, R. Tavella, M. Arstall, D. Chew, M. Worthley, C. Zeitz, J. Beltrame Tags: 464 Source Type: research

Identifying Warfarin Control With Stroke and Bleed Risk Scores
Warfarin decreases stroke risk in atrial fibrillation patients, with efficacy and safety impacted by the quality of warfarin control, as measured by time in therapeutic range (TTR). Stroke and bleed risk scores are calculated prior to commencing warfarin, so it would be beneficial if these scores also identified likely warfarin control. Some studies have investigated CHADS2, CHA2DS2VASc, and HASBLED individually for this purpose, but application of all scores to diverse ethnic populations and at sites with differing overall control has not been investigated.
Source: Heart, Lung and Circulation - November 28, 2017 Category: Cardiology Authors: Nijole Bernaitis, Chi Keong Ching, Tony Badrick, Shailendra Anoopkumar-Dukie Tags: Brief Communication Source Type: research

Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Stroke: Meta-Analysis of Randomised Trials
Patent foramen ovale (PFO) is a common anatomic variant associated with cryptogenic stroke. Percutaneous PFO closure in these patients to prevent recurrent neurological events has been controversial for decades, and mixed results have been reported from past and recent observational and randomised studies. This meta-analysis of randomised trials aims to compare the efficacy and safety of PFO closure with medical therapy for cryptogenic stroke patients.
Source: Heart, Lung and Circulation - March 12, 2018 Category: Cardiology Authors: Tom Kai Ming Wang, Michael Tzu Min Wang, Peter Ruygrok Tags: Original Article Source Type: research